Genentech, Inc.
Genentech Receives Final Notification Upholding Cabilly Patent in Reexamination Proceeding
Published in Drug Week, March 13th, 2009
Genentech, Inc. (NYSE: DNA) announced that the U.S. Patent and Trademark Office has issued a Notice of Intent to Issue a Reexamination Certificate (NIRC) confirming the patentability of all claims of the Cabilly et al. patent, U.S. Patent No. 6,331,415 (Cabilly patent), of which claims 21 through 32 were amended in a manner that does not affect the commercial importance of the patent. This favorable decision by the Patent Office is final and unappealable.
“We have always believed that the Cabilly patent represents a new and significant innovation in biotechnology, and we are very pleased with the Patent Office’s final decision in this reexamination proceeding,” said...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2009-03-13)
More Articles from Drug Week
- American Journal of Pathology
Lowering your cholesterol may decrease your risk of cancer - American Journal of Pathology
New technique for cancer screening - Burnham Institute
Scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses - Federation of American Societies for Experimental Biology
'Neurological work-arounds' offer hope to people with monoamine-related disorders - Harvard School of Public Health
Diets that reduce calories lead to weight loss, regardless of carbohydrate, protein or fat content - JAMA and Archives Journals
Most prison inmates with HIV do not receive appropriate treatment immediately following release - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
